



Escherichia coli are one of the most frequently occurring 
members of the family of bacteria called the Enterobacteriaceae 
and are major multi-drug resistant pathogens of both 
community and hospital-acquired infections.[1] They have 
been renowned for the production of extended-spectrum 
β-lactamases (ESBL) and have in recent times also shown 
remarkable production of the carbapenemases leading to 
limited antibiotic treatment options.[1,2] This is particularly 
problematic in countries like Nigeria, where the carbapenems 
are considered agents of last resort in treating infections due 
to multidrug-resistant bacteria.[3]
Although ESBL production among E. coli isolates in Nigeria 
as well as globally are remarkably high, the burden of 
carbapenemase-producing E. coli in this environment is mostly 
unknown.[1-4] Moreso, only a few studies have reported the 
detection of these enzymes in the country.[1-4] This limitation 
increases when the focus is on the South-eastern parts of the 
country.
The objectives of this study were to determine the prevalence 
of New-Delhi Metallo Beta-Lactamase ((NDM) and 
oxacillinase-48 (OXA-48) genes in E. coli isolates from 
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clinical specimens in a tertiary hospital in the South-eastern 
region of Nigeria and to determine the antibiotic susceptibility 
pattern of these isolates.
MateRIals and Methods
Study population
One hundred and eighty-seven nonduplicate E. coli isolates 
were collected consecutively from clinical specimens of 
patients submitted to the Medical Microbiology laboratory of 
Nnamdi Azikiwe University Teaching Hospital (NAUTH), 
a tertiary health institution and major referral centre serving 
individuals from most parts of South-East, Nigeria. The study 
was carried out between March and October 2018, and it 
included all Gram-negative bacilli isolated during the study 
duration.
Ethical consideration
This work received approval from the research and ethics 
committee of NAUTH, Nnewi, with reference number 
NAUTH/CS/66/VOL. 10/190/2017/100.
Specimen collection and transport
All the isolates used in this study were obtained from clinical 
specimens that had been collected and immediately transported 
in their appropriate specimen containers to the NAUTH 
medical microbiology laboratory for processing within 1 h of 
collection. Blood was collected aseptically in blood culture 
bottles containing brain heart infusion (Oxoid, UK). Urine was 
collected in a sterile wide bore and screw-capped containers, 
while wound swabs were collected using sterile single-use 
cotton swabs.
Bacteria isolation
Blood cultures were incubated aerobically at 35°C–37°C for 
7days and sub-cultured onto chocolate agar and Mac Conkey 
agar (Oxoid, UK) on days 2, 5 and 7, whichever yielded growth 
first. Other specimens were cultured directly on Chocolate agar 
and Mac Conkey agar (Oxoid, UK) and incubated aerobically 
at 35°C–37°C for 18–24 h. Then growth was confirmed by 
visible colonies on the surface of the culture media.
Bacterial identification
The isolated organisms were Gram-stained, and all Gram-negative 
bacilli were then subjected to standard conventional biochemical 
tests for E. coli identification. These tests include lactose 
fermentation on Mac Conkey agar, indole production, citrate 
utilization, Voges Proskauer), and the hanging drop test for 
motility.[5] All motile, indole producing, lactose fermenting 
isolates which were negative for citrate utilization and Voges 
Proskauer tests were suspected to be E. coli. The suspected 
E. coli isolates were then confirmed as E. coli by the production 
of a greenish metallic sheen when sub-cultured on Eosin 
Methylene Blue Agar and incubated for 18–24 h at 37°C.[5]
Antimicrobial susceptibility testing
The antimicrobial susceptibility testing (AST) was 
performed according to the techniques developed by 
Kirby–Bauer  and descr ibed in  the  Cl inical  and 
Laboratory Standard Institute (CLSI) standards for 
AST.[6] The organisms were tested against the following 
antibiotics: ampicillin (10 µg), amoxicillin-clavulanate 
(20/10 µg), cefuroxime (30 µg), cefotaxime (30 µg), 
ceftazidime (30 µg), cefepime (30 µg), meropenem 
(10 µg), ertapenem (10 µg), doripenem (10 µg), gentamicin 
(30 µg), ciprofloxacin (5ug), and tetracycline (30 µg) (Oxoid 
Ltd UK). Incubation was performed at 37°C for 18–24 h. 
After incubation, the inhibition zone was measured for each 
antibiotic produced by the E. coli isolates was measured in 
millimetres, and this was interpreted as sensitive, intermediate, 
or resistant based on the CLSI standard interpretive criteria.[6] 
E. coli ATCC 25922 was used to control the quality of the test.[6]
Screening for suspected carbapenemase production
The isolates were screened for carbapenem resistance 
and hence possible carbapenemase producers according 
to the 2017 CLSI guidelines.[6] In this method, 10 µg 
carbapenem antibiotic (ertapenem and meropenem) 
discs (Oxoid, UK) were placed on the surface of Mueller 
Hinton Agar (MHA) (Oxoid, UK) plates inoculated with 
each isolate of E. coli and then incubated at 37°C for 24 
h after which zones of inhibition were read off.[6] Isolates 
showing inhibition zones ≤22 mm or ≤21 mm in diameter 
for meropenem or ertapenem respectively were considered 
as suspected carbapenemase producers.[5,6] They were then 
subjected to phenotypic confirmation using the modified hodge 
test (MHT).[5,6] E. coli ATCC 25922 was used to control the 
quality of the screening test.
Phenotyp ic  conf i rmat ion  o f  carbapenemase 
production (modified hodge test)
In this method, a suspension of E. coli ATCC 25922 equivalent 
to 0.5 McFarland turbidity standard was prepared. The E. coli 
suspension was then diluted 1:10 by adding 0.5 ml of the E. coli 
suspension to 4.5 ml of saline. A lawn of the 1:10 dilution of 
E. coli ATCC 25922 was evenly streaked onto MHA plates 
using sterile cotton swabs and then allowed to dry for 3–5 min. 
Following this, one meropenem antibiotic disc (Oxoid, UK), 
was placed on the centre surface of the MHA plate. The test 
organisms were streaked in a straight line from one edge of 
each meropenem disc to the edge of the plate. Following this, 
the plates were incubated at 37°C for 24 h. After incubation, 
the plates were examined for a clover-leaf type indentation 
at the intersection of the test organism and E. coli. ATCC 
25922 within the zone of inhibition of the meropenem 
disc.[6] Klebsiella pneumoniae ATCC1705 and K. pneumoniae 
ATCC1706 were used as positive and negative controls.[6]
DNA extraction
Bacteria DNA from the E. coli isolates was extracted using a 
boiling method for DNA extraction.[7] Five hundred microlitre 
of an overnight broth culture of the bacterial isolate in Luria 
Bertani medium was added into an Eppendorf tube. To this, 
1000 µl (i.e., 1 ml) of normal saline was added and correctly 
mixed using a vortex. Next was to spin the suspension at 
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14,000 rpm for 5 min. After spinning, the supernatant was 
discarded, while the sediments were resuspended in 1000 µl of 
normal saline and mix properly using a vortex mixer. This was 
repeated three times. After this, the supernatant was discarded 
again. The sediments were then resuspended in 500 µl of DNA 
elution buffer and vortexed. Then the mixture was heated 
on a heating block at 95°C for 20 min. The heated bacterial 
suspension was fast cooled on ice and spun for 3 min at 14,000 
rpm. The supernatant containing the DNA was transferred to 
a 1.5 ml microcentrifuge tube and stored at-20°C for further 
downstream reactions.[7]
Molecular detection of New-Delhi metallo beta-lactamase 
and oxacillinase-48
Conventional polymerase chain reaction (PCR) was used to 
amplify genes encoding NDM and OXA-48 group carbapenemases 
employing the use of previously published protocols with slight 
modifications.[8,9] Specific Primer sequences for the detection of 
blaNDM and blaOXA-48 (Inqaba, SA) were used [Table 1].
The PCR conditions were as follows: OXA-48; Initial 
denaturation at 95°C for 5 min, then 35 cycles of denaturation 
at 95°C for 30 s, annealing at 50°C for 30 s, extension at 
72°C for 40 s, then final extension at 72°C for 5 min.[8] NDM; 
Initial denaturation at 95°C for 5 min, followed by 35 cycles 
of denaturation at 95°C for 30 s, annealing at 51°C for 30 s, 
extension, 72°C for 60 s, then final extension at 72°C for 
5 min.[9] The PCR products were pipetted onto wells on a 1.5% 
agarose gel in an electrophoretic tank and resolved at 130V 
for 25 min and visualized on a blue light trans-illuminator.[8,9]
Results
Out of the 187  E. coli isolates, 41 (21.9%) were 
carbapenem-resistant, while 21 (11.3%) of the isolates 
were confirmed as carbapenemase producers. Urine 
was the most frequent specimen harbouring the E. coli 
isolates 115 (61.5%), followed by wounds 24 (12.8%). All 
phenotypically positive carbapenemase producers showed a 
clover-leaf type indentation on MHT [Figure 1]. NDM was 
detected in 3/187 (1.6%) of the E. coli isolates [Figure 2], 
while the OXA-48 gene was detected in 12/187 (6.4%) of 
the isolates [Figure 3].
The E. coli isolates were most susceptible to meropenem 
170/187 (90.9%), and this was closely followed by ertapenem 
163/187 (87.2%), and doripenem 152/187 (81.3%). The highest 
level of resistance was recorded against ampicillin 185/187 (99%), 
followed by tetracycline 180/187 (96.3%) [Table 2].
The prevalence of carbapenem-resistant  E. coli in 
the total sample population was 41/187 (21.9%), 
while that of carbapenemase-producing E. coli was 
21/187 (11.23%) [Table 3].
dIscussIon
The global emergence and dissemination of carbapenemases 
among Gram-negative bacteria  are considered a 
significant public health challenge. Characterization of 
carbapenemase-producing Enterobacteriaceae has been 
done globally as well as in Nigeria. Still, information on the 
emergence and spread of these group of organisms in the 
South-eastern parts of Nigeria are limited.[1-4]
The antibiotic susceptibility patterns of the E. coli isolates 
revealed that the organisms had the highest resistance 
rates to Ampicillin 185/187 (99%), and Tetracycline 
180/187 (96.3%), but reduced resistance to the carbapenem 
class of antibiotics (Meropenem, Doripenem, and Ertapenem), 
with meropenem being the least resistant of them 9/187 (4.8%). 
Similar findings were observed in Sudan and Mexico with the 
highest resistance rates observed in tetracycline (97.7%)[10] and 
ampicillin (70.8%)[11] respectively.
The carbapenem resistance prevalence ranging from 4.8% 
to 10.2% observed in this study was quite high for a drug 
Table 1: Primer sequences used in the study
Primers Sequence (5′→3′)a Location Product size
NDM (F) GCACACTTCCTATCTCGACATGC blaNDM 209 bp
NDM (R) CCATACCGCCCATCTTGTCC blaNDM, reverse primer
OXA-48 (F) TTGGTGGCATCGATTATCGG blaOXA-48 743 bp
OXA-48 (R) GAGCACTTCTTTTGTGATGGC blaOXA-48, reverse primer
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Figure 1: Modified hodges test. A is a lawn of Escherichia coli ATCC 
25922; B is modified hodges test negative control (Klebsiella pneumoniae 
ATCC 1706); C is an Escherichia coli test isolate positive on modified 
hodges test, thus showing clover leaf appearance at its intersection with 
the inhibition zone of the lawn of Escherichia coli ATCC 25922; D is 
modified hodges test positive control (Klebsiella pneumoniae ATCC 1705)
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class which has been reserved for use only as a last resort. 
This was similar to other studies done in Kenya and Kuwait, 
wherein low resistance rates (5%–8%) to the carbapenems 
were observed.[12,13] A higher prevalence of 50/229 (21.8%) 
was observed in isolates from a surgical Intensive Care Unit 
of a hospital in Egypt.[14] This result, however, was in sharp 
contrast to an Egyptian study that revealed 100% resistance 
to meropenem.[15] The reduced rates of resistance to the 
carbapenems in this study were probably because of the high 
cost of purchase of carbapenems in Nigeria, which makes it 
less available for use, thus resulting in decreased selection 
pressure for development of resistance. Also, the varying 
antibiotic resistance rates observed may be attributed to 
varying levels of regulations regarding antibiotic usage in 
different countries.
The 11.23% prevalence of carbapenemase production in 
the E. coli isolates was slightly lower than the prevalence 
of carbapenemase-producing E. coli obtained in other 
Nigerian studies-Lagos (12.4%),[2] Kano (14%),[4] while 
also using various phenotypic detection techniques. 
A much lower prevalence of 3.5% was observed in Italy.[16] 
Contrasting rates were also observed in other studies with 
higher prevalences reported in Pakistan (69%)[17] and 
Tanzania (35%).[18] The varying results obtained from these 
studies may be attributed to differences in the phenotypic 
detection methods used, as well as different levels of 
Table 2: Susceptibility patterns of the Escherichia coli isolates
Antibiotic Number of isolates Susceptible, n (%) Intermediate, n (%) Resistant, n (%)
Meropenem (MEM) 187 170 (90.9) 8 (4.3) 9 (4.8)
Doripenem (DOR) 187 152 (81.3) 16 (8.6) 19 (10.2)
Ertapenem (ETP) 187 163 (87.2) 11 (5.9) 13 (6.9)
Cefuroxime (CXM) 187 10 (5.4) 82 (43.9) 95 (51)
Cefotaxime (CTX) 187 81 (43.3) 20 (10.7) 86 (46)
Ceftazidime (CAZ) 187 93 (49.7) 15 (8.0) 79 (42.3)
Cefepime (FEP) 187 91 (48.7) 15 (8.0) 81 (43.3)
Ampicillin (AMP) 187 1 (0.5) 1 (0.5) 185 (99)
Amoxicillin-clavulanate (AMC) 187 75 (40.1) 52 (27.8) 60 (32.1)
Tetracycline (TE) 187 6 (3.2) 1 (0.5) 180 (96.3)
Ciprofloxacin (CIP) 187 24 (12.8) 43 (23) 120 (64.2)
Gentamycin (GM) 187 68 (36.4) 22 (11.76) 97 (51.9)
Table 3: Characteristics of the carbapenemase-producing Escherichia coli isolates
Isolate code Source of isolation Hospital unit MHT NDM detection OXA-48 detection Gel Electrophoresis lane
C30 Blood FMW Positive Negative Positive 1
C70 Urine MMW Positive Negative Positive 2
C158 Urine GOPD Positive Negative Positive 3
C64 Urine MMW Positive Negative Positive 4
C107 Blood MMW Positive Negative Negative 5
C80 Wound A\E Positive Negative Negative 6
C85 Urine FMW Positive Negative Positive 7
C105 Wound SOP Positive Negative Negative 8
C42 Wound MMW Positive Positive Positive 9
C69 Urine GOPD Positive Negative Negative 10
C29 Urine GOPD Positive Negative Positive 11
C67 Wound MOP Positive Negative Negative 12
C168 Wound GOPD Positive Negative Negative 13
C87 Urine A\E Positive Negative Negative 14
C63 Urine FMW Positive Negative Positive 15
C39 Urine CHOP Positive Negative Positive 16
C65 Urine GOPD Positive Negative Positive 17
C89 Wound GOPD Positive Negative Negative 18
C138 Urine GOPD Positive Positive Positive 19
C135 Urine FMW Positive Positive Negative 20
C91 Urine FMW Positive Negative Positive 21
Total 21 3 (1.6%) 12 (6.4%)
GOPD: General out-patient department, MMW: Male medical ward, A\E: Accident and emergency, FMW: Female medical ward, SOP: Surgical 
out-patient, CHOP: Children out patient, MOP: Medical out patient
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application of antimicrobial stewardship programs in other 
settings.
The prevalence of NDM gene expression in E. coli clinical 
isolates in this study was similar to the prevalence of NDM 
observed in Kuwait (2.7%),[19] Uganda (2.6%)[20] and 
Pakistan (1.2%).[13] A higher prevalence of 12.2% was reported 
in Iran among clinical bacteria isolates,[21] but a slightly lower 
rate (0.8%) was noted among E. coli clinical isolates in Kano.[22] 
The observed prevalence of OXA-48 gene in E. coli clinical 
isolates was 6.4%. This prevalence was only slightly lower 
in a Lagos study (3.4%),[2] as well as in Tanzania (4.8%),[18] 
where the prevalence of OXA-48 gene was obtained from 
carbapenemase-producing Enterobacteriaceae isolates. A much 
higher rate was observed in Saudi Arabia.[23] Variations in the 
prevalence of these carbapenemase genes in the various regions 
may be due to varying sample sizes and specimens, cross 
border migrations and geographical distribution of NDM and 
OXA type genes, which contributes significantly to the types 
and percentage of carbapenemase enzymes being produced in 
each locality.
conclusIon
The findings from this study prove that NDM and OXA-48 
carbapenemase mediated resistance occurred in the study 
location, and this may further limit treatment options in the 
region since these carbapenems are currently being used as 
agents of last resort in the south-eastern parts of Nigeria. 
Hence, a reinforcement of infection prevention and control 
practices in the hospital will be required to curb the propagation 
of these resistant organisms.
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